Repligen (RGEN) Inventory (2011 - 2026)

Repligen (RGEN) has 16 years of Inventory data on file, last reported at $179.3 million in Q1 2026.

• Inventory for Q1 2026 came in at $179.3 million, up 17.08% year-over-year; the trailing twelve-month figure through Mar 2026 was $179.3 million (up 17.08% YoY), and the FY2025 annual result was $170.5 million, up 19.23% from the prior year.
• Inventory climbed to $179.3 million in Q1 2026 per RGEN's latest filing, from $170.5 million in the prior quarter.
• Over five years, Inventory peaked at $244.7 million in Q1 2023 and troughed at $143.0 million in Q4 2024.
• A 5-year average of $198.0 million and a median of $198.0 million in 2024 frame the typical range for Inventory.
• The sharpest annual moves came in 2022 and 2024: Inventory surged 95.19% in 2022, then dropped 29.34% in 2024.
• A 5-year view of Inventory shows it stood at $238.3 million in 2022, then fell by 15.09% to $202.3 million in 2023, then retreated by 29.34% to $143.0 million in 2024, then increased by 19.23% to $170.5 million in 2025, then climbed by 5.16% to $179.3 million in 2026.
• Business Quant data shows RGEN's Inventory at $179.3 million in Q1 2026, $170.5 million in Q4 2025, and $160.3 million in Q3 2025.